Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma
1990

Loss of Immunoregulatory Molecules in Bladder Cancer

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): A.M.E. Nouri, M.E.F. Smith, D. Crosby, R.T.D. Oliver

Primary Institution: The London Hospital, Imperial Cancer Research Fund

Hypothesis

Do alterations in the expression of immunoregulatory molecules occur in transitional cell carcinoma?

Conclusion

A significant number of bladder tumors exhibit alterations in the expression of immunoregulatory molecules, which may help them evade immune detection.

Supporting Evidence

  • Complete loss of HLA-A,B,C antigens was observed in one of 18 cases.
  • Moderate to strong expression of HLA-A,B,C antigens was found in 10 of 18 cases.
  • Two cases showed complete loss of LFA-3 molecules.
  • Selective loss of HLA-Bw6 was seen in one of 18 cases.

Takeaway

Some bladder cancer cells can hide from the body's immune system by changing how they show certain markers, making it harder for the immune system to find and attack them.

Methodology

Immunohistochemical staining of bladder tissue sections from patients with transitional cell carcinoma and normal specimens.

Limitations

The study used post-mortem tissue, which may not represent the live tumor environment accurately.

Participant Demographics

18 patients with transitional cell carcinoma, including 5 females (ages 50-76) and 13 males (ages 48-85).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication